A consortium led by Neotherix has won a further grant to develop EktoTherix™ - a novel regenerative tissue scaffold for the repair of wounds left by surgical procedures such as those following skin cancer treatment. The £414,000 project is funded by Technology Strategy Board and follows earlier EktoTherix projects at Feasibility (2009) and Developing Therapeutics 1 (2010) stages, also supported by TSB. Neotherix will collaborate with Lorien Engineering Solutions and Smith & Nephew Advanced Wound Management to complete the steps needed for EktoTherix to enter a First in Man clinical trial at the start of 2013. The milestone of collation and reporting of clinical data is due in September 2013. Neotherix is targeting a market launch in mid-2014 for the product, which can also be used for the repair of other acute wounds such as lacerations and surgical wounds.
See the full Neotherix press release.
Links to Lorien Engineering Solutions , Smith & Nephew Advanced Wound Management and Technology Strategy Board .